Isbn: 9783659170607 - Nasal and Pulmonary Drug Delivery System: Advancement in Naso-pulmonary Drug Delivery System (6 results)

ISBN: 
Refine with Advanced Search

Refine your search

  • Books (6)

to

Custom price range (£)

to

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2012

    3659170607 / 9783659170607

    • Softcover

    Seller: Mispah books, Redhill, SURRE, United KingdomMispah books

    4-star seller
    Contact seller

    Condition: Used - As new

    £ 124.00

    £ 25.00 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: 1 available

    Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2012

    3659170607 / 9783659170607

    • Softcover

    Seller: preigu, Osnabrück, Germanypreigu

    5-star seller
    Contact seller

    Condition: New

    £ 173.62

    £ 60.20 shipping 
    Ships from Germany to U.S.A.

    Quantity: 5 available

    Taschenbuch. Condition: Neu. Nasal and Pulmonary Drug Delivery System | Advancement in Naso-pulmonary Drug Delivery System | Rahul Satapara (u. a.) | Taschenbuch | 76 S. | Englisch | 2012 | LAP LAMBERT Academic Publishing | EAN 9783659170607 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. …

  • Language: English

    Published by LAP LAMBERT Academic Publishing Jun 2012, 2012

    3659170607 / 9783659170607

    • Softcover
    • Print on Demand

    Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermanyBuchWeltWeit Ludwig Meier e.K.

    5-star seller
    Contact seller

    Condition: New

    £ 43.41

    £ 19.78 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The widespread interest in intranasal route for therapeutic purposes other than the topically nasal drug delivery arises from the particular anatomical, physiological and histological characteristics of the nasal cavity, which provides potential for rapid systemic drug absorption and quick onset of action. In addition, intranasal absorption avoids the gastrointestinal and hepatic presystemic metabolism, enhancing drug bioavailability in comparison with that obtained after gastrointestinal absorption. Growing attention has been given to the potential of a pulmonary route as an non-invasive administration for systemic delivery of therapeutic agents (mainly peptides and proteins) due to the fact that the lungs could provide a large absorptive surface area (up to 100 m2 ) but extremely thin (0.1 m 0.2 m) absorptive mucosal membrane and good blood supply. However, recent advances show great promise, but pulmonary delivery of peptides and proteins is complicated by the complexity of the anatomic structure of the human respiratory system and the effect of disposition exerted by the respiration process. 76 pp. Englisch.…

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2012

    3659170607 / 9783659170607

    • Softcover
    • Print on Demand

    Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH

    5-star seller
    Contact seller

    Condition: New

    £ 43.41

    £ 30.10 shipping 
    Ships from Germany to U.S.A.

    Quantity: 1 available

    Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The widespread interest in intranasal route for therapeutic purposes other than the topically nasal drug delivery arises from the particular anatomical, physiological and histological characteristics of the nasal cavity, which provides potential for rapid systemic drug absorption and quick onset of action. In addition, intranasal absorption avoids the gastrointestinal and hepatic presystemic metabolism, enhancing drug bioavailability in comparison with that obtained after gastrointestinal absorption. Growing attention has been given to the potential of a pulmonary route as an non-invasive administration for systemic delivery of therapeutic agents (mainly peptides and proteins) due to the fact that the lungs could provide a large absorptive surface area (up to 100 m2 ) but extremely thin (0.1 m 0.2 m) absorptive mucosal membrane and good blood supply. However, recent advances show great promise, but pulmonary delivery of peptides and proteins is complicated by the complexity of the anatomic structure of the human respiratory system and the effect of disposition exerted by the respiration process.…

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2012

    3659170607 / 9783659170607

    • Softcover
    • Print on Demand

    Seller: moluna, Greven, Germanymoluna

    5-star seller
    Contact seller

    Condition: New

    £ 36.91

    £ 42.13 shipping 
    Ships from Germany to U.S.A.

    Quantity: Over 20 available

    Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Satapara RahulMr.Rahul G. Satapara is doing M.pharma. in Pharmaceutics from Gujarat Technological University. He also doing Post graduate diploma in patent lawfrom Nalsar university,Hyderabad.He has completed D.Pharma. & B.Pharma. .…

  • Language: English

    Published by LAP LAMBERT Academic Publishing Jun 2012, 2012

    3659170607 / 9783659170607

    • Softcover
    • Print on Demand

    Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000

    5-star seller
    Contact seller

    Condition: New

    £ 173.62

    £ 51.60 shipping 
    Ships from Germany to U.S.A.

    Quantity: 1 available

    Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The widespread interest in intranasal route for therapeutic purposes other than the topically nasal drug delivery arises from the particular anatomical, physiological and histological characteristics of the nasal cavity, which provides potential for rapid systemic drug absorption and quick onset of action. In addition, intranasal absorption avoids the gastrointestinal and hepatic presystemic metabolism, enhancing drug bioavailability in comparison with that obtained after gastrointestinal absorption. Growing attention has been given to the potential of a pulmonary route as an non-invasive administration for systemic delivery of therapeutic agents (mainly peptides and proteins) due to the fact that the lungs could provide a large absorptive surface area (up to 100 m2 ) but extremely thin (0.1 ¿m ¿ 0.2 ¿m) absorptive mucosal membrane and good blood supply. However, recent advances show great promise, but pulmonary delivery of peptides and proteins is complicated by the complexity of the anatomic structure of the human respiratory system and the effect of disposition exerted by the respiration process.OmniScriptum SRL, Str. Armeneasca 28/1, office 1, 2012 Chisinau 76 pp. Englisch.…